Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer

US Patent 10618967 · Granted Apr 14, 2020

Estimated economic value: $1,772,000

Assignee

Inventors

View full patent text on Google Patents →